BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14570890)

  • 21. Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.
    Beg OU; Meng MS; Skarlatos SI; Previato L; Brunzell JD; Brewer HB; Fojo SS
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3474-8. PubMed ID: 2110364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
    Heeren J; Niemeier A; Merkel M; Beisiegel U
    J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake.
    Merkel M; Heeren J; Dudeck W; Rinninger F; Radner H; Breslow JL; Goldberg IJ; Zechner R; Greten H
    J Biol Chem; 2002 Mar; 277(9):7405-11. PubMed ID: 11751882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans.
    Nielsen MS; Brejning J; García R; Zhang H; Hayden MR; Vilaró S; Gliemann J
    J Biol Chem; 1997 Feb; 272(9):5821-7. PubMed ID: 9038197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.
    Vilella E; Joven J; Fernández M; Vilaró S; Brunzell JD; Olivecrona T; Bengtsson-Olivecrona G
    J Lipid Res; 1993 Sep; 34(9):1555-64. PubMed ID: 8228638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH; Bisgaier CL; Aalto-Setälä K; Radner H; Ramakrishnan R; Levak-Frank S; Essenburg AD; Zechner R; Breslow JL
    J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.
    Weinstein MM; Yin L; Beigneux AP; Davies BS; Gin P; Estrada K; Melford K; Bishop JR; Esko JD; Dallinga-Thie GM; Fong LG; Bensadoun A; Young SG
    J Biol Chem; 2008 Dec; 283(50):34511-8. PubMed ID: 18845532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells.
    Sivaram P; Klein MG; Goldberg IJ
    J Biol Chem; 1992 Aug; 267(23):16517-22. PubMed ID: 1644832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters.
    Sendak RA; Berryman DE; Gellman G; Melford K; Bensadoun A
    J Lipid Res; 2000 Feb; 41(2):260-8. PubMed ID: 10681410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle.
    Sattler W; Levak-Frank S; Radner H; Kostner GM; Zechner R
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):15-9. PubMed ID: 8761445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis.
    Sendak RA; Bensadoun A
    J Lipid Res; 1998 Jun; 39(6):1310-5. PubMed ID: 9643364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.
    Yagyu H; Lutz EP; Kako Y; Marks S; Hu Y; Choi SY; Bensadoun A; Goldberg IJ
    J Biol Chem; 2002 Mar; 277(12):10037-43. PubMed ID: 11790777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lipoprotein lipase].
    Ikeda Y; Takagi A; Yamamoto A
    Nihon Rinsho; 1994 Dec; 52(12):3146-52. PubMed ID: 7853703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding.
    Hill JS; Yang D; Nikazy J; Curtiss LK; Sparrow JT; Wong H
    J Biol Chem; 1998 Nov; 273(47):30979-84. PubMed ID: 9812994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts.
    Makoveichuk E; Castel S; Vilaró S; Olivecrona G
    Biochim Biophys Acta; 2004 Nov; 1686(1-2):37-49. PubMed ID: 15522821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats.
    Oscarsson J; Ottosson M; Vikman-Adolfsson K; Frick F; Enerbäck S; Lithell H; Edén S
    J Endocrinol; 1999 Feb; 160(2):247-55. PubMed ID: 9924194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates.
    Ben-Zeev O; Mao HZ; Doolittle MH
    J Biol Chem; 2002 Mar; 277(12):10727-38. PubMed ID: 11796709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.